Biomaterial Database

[A new antibiotic in the treatment of infections caused by gram positive bacteria: lincomycin. In vitro study and clinical experience]. 1967

A Bertrand, and F Janbon

UI	MeSH Term	Description	Entries
D008034	Lincomycin	An antibiotic produced by Streptomyces lincolnensis var. lincolnensis. It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections.	Lincolnensin,Lincomycin, (2S-cis)-Isomer,Epilincomycin,Lincocin,Lincomycin A,Lincomycin Hydrochloride,Lincomycin Monohydrochloride,Lincomycin Monohydrochloride, (2S-cis)-Isomer,Lincomycin Monohydrochloride, (L-threo)-Isomer,Lincomycin Monohydrochloride, Hemihydrate,Lincomycin, (L-threo)-Isomer,Hemihydrate Lincomycin Monohydrochloride
D008088	Listeriosis	Infections with bacteria of the genus LISTERIA.	Listeria Infections,Infections, Listeria,Infection, Listeria,Listeria Infection,Listerioses
D008171	Lung Diseases	Pathological processes involving any part of the LUNG.	Pulmonary Diseases,Disease, Pulmonary,Diseases, Pulmonary,Pulmonary Disease,Disease, Lung,Diseases, Lung,Lung Disease
D008297	Male		Males
D010000	Osteitis	Inflammation of the bone.	Bone Inflammation,Inflammation, Bone
D010038	Otorhinolaryngologic Diseases	Pathological processes of the ear, the nose, and the throat, also known as the ENT diseases.	Otolaryngologic Diseases,ENT Diseases,Otolaryngological Diseases,Otorhinolaryngologic Disease,Otorhinolaryngological Disease,Disease, ENT,Disease, Otolaryngologic,Disease, Otolaryngological,Disease, Otorhinolaryngologic,Disease, Otorhinolaryngological,Diseases, ENT,Diseases, Otolaryngologic,Diseases, Otolaryngological,Diseases, Otorhinolaryngologic,Diseases, Otorhinolaryngological,ENT Disease,Otolaryngologic Disease,Otolaryngological Disease,Otorhinolaryngological Diseases
D011008	Pneumococcal Infections	Infections with bacteria of the species STREPTOCOCCUS PNEUMONIAE.	Streptococcus pneumoniae Infections,Infections, Pneumococcal,Infections, Streptococcus pneumoniae,Pneumococcal Diseases,Disease, Pneumococcal,Diseases, Pneumococcal,Infection, Pneumococcal,Infection, Streptococcus pneumoniae,Pneumococcal Disease,Pneumococcal Infection,Streptococcus pneumoniae Infection
D001982	Bronchial Diseases	Diseases involving the BRONCHI.	Bronchial Disease,Disease, Bronchial,Diseases, Bronchial
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328	Adult	A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.	Adults

Related Publications

A Bertrand, and F Janbon

[Lincomycin in the treatment of gram positive infections].

January 1968, La Prensa medica mexicana,

A Bertrand, and F Janbon

Treatment of infections caused by antimicrobial-resistant gram-positive bacteria.

September 2010, The American journal of the medical sciences,

A Bertrand, and F Janbon

New drugs for osteoarthritis and infections caused by gram-positive bacteria.

January 2000, Home healthcare nurse,

A Bertrand, and F Janbon

Infections caused by Gram-positive bacteria: situation and challenges of treatment.

January 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,

A Bertrand, and F Janbon

The fluoroquinolones as treatment for infections caused by gram-positive bacteria.

March 1994, The Journal of antimicrobial chemotherapy,

A Bertrand, and F Janbon

Clinical experience of cefotaxime in infections caused by gram-positive pathogens.

January 1985, Infection,

A Bertrand, and F Janbon

[Daptomycin in infections caused by gram-positive bacteria. Introduction].

February 2012, Enfermedades infecciosas y microbiologia clinica,

A Bertrand, and F Janbon

[Aztreonam--new antibiotic for treating infections caused by gram-negative aerobic bacteria].

January 1993, Wiadomosci lekarskie (Warsaw, Poland : 1960),